Skip to main content
Caplight Logo









Therorna Inc.

Therorna Inc.

Private
BeijingHealthcare & Life Scienceshttps://therorna.com/

Last Round

Series A

Jun 20, 2022

Total Funding Raised

$56.9M

Company Overview

Therorna Inc. is a biotechnology company that develops circular RNA (circRNA)-based therapies and vaccines to address unmet medical needs in oncology and autoimmune diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

RNA therapeuticscircular RNAcircRNAdrug discoverybiotechnologygene expressionpreclinical researchtherapeutic modalitiesGMP manufacturingbiotech startupdrug developmentRNA platformbiotech pipelineundruggable targetsbiotech licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Therorna Inc. Comparables

Compare Therorna Inc. with similar companies based on industry and business-model similarity.

Therorna Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CiRC Biosciences
86%
CirCode Biomedicine
86%
Suzhou CureMed Biopharma Technology Co., Ltd.
84%

Therorna Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJun 20, 2022
Pre SeedNov 29, 2021

Therorna Inc. Investors

Notable investors and investment history

Therorna Inc. investors
InvestorRounds
Tencent ExplorationSeries A
MSA CapitalSeries A
3H Health InvestmentSeries A
Cenova CapitalSeries A, Pre Seed
Sherpa Healthcare PartnersSeries A
Quan CapitalSeries A, Pre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 20, 2022

    $42M round led by Tencent Exploration and MSA Capital.

Therorna Inc. Filings

Explore SEC and related filing metadata, where available.

Therorna Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Therorna Inc.'s valuation, stock price, and market status.

Is Therorna Inc. a public or private company?

Therorna Inc. is a private company.

What is the current stock price of Therorna Inc.?

Therorna Inc. is a private company with no public stock price. Caplight tracks Therorna Inc.'s secondary market activity and provides MarketPrice estimates to Caplight users.

How much is Therorna Inc. worth (valuation)?

Valuation information for Therorna Inc. is not publicly available.

Can I buy Therorna Inc. stock?

Therorna Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Therorna Inc.'s last funding round?

Therorna Inc.'s most recent funding round was Series A on June 20, 2022.

Who are the main investors in Therorna Inc.?

Key investors in Therorna Inc. include Tencent Exploration, MSA Capital, Quan Capital.

Will Therorna Inc. IPO soon?

No public IPO plans have been announced for Therorna Inc..

How can I track Therorna Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Therorna Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBeijing
Year Founded2021
Last FundingJun 20, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?